Researchers

Results 141-160 of 333
Issue DateTitleAuthor(s)TypeМp-cat.
2014The Role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemiaDragović-Ivančević, Tijana; Kraguljac-Kurtović, Nada ; Knežević, Vesna; Bogdanović, Andrija  ; Mihaljević, Biljana ; Božić, Biljana  ; Gotić, Mirjana  Article
23M23
2014Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 studyDavies, Andrew; Merli, Francesco; Mihaljević, Biljana ; Siritanaratkul, Noppadol; Solal-Céligny, Phillippe; Barrett, Martin; Berge, Claude; Bittner, Beate; Boehnke, Axel; McIntyre, Christine;
MacDonald, David;
Article
21a+M21a+
2014Pretreatment risk factors for overall survival in patients with gastrointestinal and non-gastrointestinal mucosa associated lymphoid tissue lymphomasVirijević, Marijana  ; Peruničić-Jovanović, Maja ; Đunić, Irena  ; Novković, Aleksandra; Mihaljević, Biljana Article
23M23
2014Therapeutic Outcome of Relapsed/Refractory Hodgkin Lymphoma Patients Treated with High Dose Therapy and Autologous Stem Cell Transplant: a Single Center ExperienceTodorović, Milena R.  ; Balint, Bela J.  ; Anđelić, Boško M.; Bila, Jelena S.  ; Stanisavljević, Dejana M.  ; Vujić, Dragana S. ; Kraguljac-Kurtović, Nada ; Šefer, Dijana ; Jeličić, Jelena J. ; Mihaljević, Biljana S. Conference Paper
Mp. category will be shown later
2013A Multicenter, Randomized Phase Iii Study of Rituximab as Maintenance Treatment Versus Observation Alone in Patients with Aggressive B-Cell Lymphoma: the Agmt Nhl13 TrialJaeger, Ulrich; ...; Mihaljevic, Biljana S ; ...; (broj, koautora 18)Conference Paper
Mp. category will be shown later
2013A 10-Year Single-Center Experience in Primary Gastric Diffuse Large B Cell Lymphoma: from Presentation to Treatment and PrognosisAntic, Darko A  ; Jelicic, Jelena J ; Djurasinovic, Vladislava T; Vukovic, Vojin M ; Milic, Natasa M; Todorovic, Marija R; Bila, Jelena S  ; Andjelic, Bosko M; Jovanovic, M; Jakovic, Ljubomir R ;
Mihaljevic, Biljana S ;
Conference Paper
Mp. category will be shown later
2013Extramedullary plasmacytoma of the tongue base - A rare presentation of head and neck plasmacytomaBila, Jelena  ; Andjelic, Bosko; Bodrozic, Jelena  ; Jakovic, Ljubomir ; Perunicic-Jovanovic, Maja; Vidović, Ana  ; Todorović, Milena  ; Mihaljević, Biljana Article
23M23
2013Analysis ofthe long term survival of patients with follicular lymphoma-our experienceAntić, Darko  ; Bila, Jelena  ; Mihaljević, Biljana ; Todorović, Milena  ; Anđelić B; Đurašinović VArticle
53M53
2013CD5-positive versus CD5-negative diffuse large B-cell lymphoma treated with immunochemotherapy: Is there a difference?Marisavljević, Dragomir Ž.  ; Marković, Olivera B.  ; POPOVIĆ, LAZAR S.  ; JOVANOVIĆ, DARJANA V.; Mihaljević, Biljana S. ; Gorana, Matovina Brko G. ; R. ŽivkovićConference Paper
Mp. category will be shown later
2013Subcutaneous Rituximab and Chemotherapy Achieves Similar Trough Levels, Safety, and Response as Intravenous Rituximab in First-Line Follicular Lymphoma: Stage 1 Results of the Phase 3 Sabrina StudyDavies, Andrew; Merli, Francesco; Mihaljevic, Biljana S ; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; McIntyre, Christine; Barrett, Martin; Macdonald, DavidConference Paper
Mp. category will be shown later
2013Differences in baseline characteristics and survival rates between GCB and non-GCB diffuse large B-cell lymphoma treated with rituximab based immunochemotherapyMarisavljević, Dragomir Ž.  ; Marković, Olivera B.  ; JOVANOVIĆ, DARJANA V.; Mihaljević, Biljana S. ; R. Živković; NIKIN, ZORAN R.Conference Paper
Mp. category will be shown later
2013Orbital and Ocular Adnexal Malt (Mucosa-Associated Lymphoid Tissue) Lymphomas, Ten Year ExperienceSmiljanic, Mihailo; Milosevic, Rajko A; Antic, Darko A  ; Andjelic, Bosko M; Djurasinovic, Vladislava T; Todorovic, Marija R; Mihaljevic, Biljana S Conference Paper
Mp. category will be shown later
2013Immunoreactivity to food antigens in patients with plasmacytoma and multiple myelomaKolundžija, Branka S. ; Matić, Ivana Z.  ; Milica Djordjevic; Đorđić Crnogorac, Marija J.  ; Damjanović Veličković, Ana B.  ; Bila Dubaić, Jovana M.  ; S. Ristić; Mihaljević, Biljana S. ; R. Dušan; Juranić, Zorica D.  Conference Paper
Mp. category will be shown later
2013Prognostic Significance of Low Lymphocytes Count in the Patients with Diffuse Large B Cell Lymphoma (DLBCL)Markovic, Olivera B; Popovic, Lazar S  ; Marisavljevic, Dragomir Z; Jovanovic, Darjana; Mihaljevic, Biljana S ; Stanisavljevic, Dejana M  ; Hajder, Jelena; Zivkovic, Radmila R; Petrovic, Dragana; Stanisavljevic, Natasa S;
Matovina-Brko, Gorana; Todorovic, Milena R; Bila, Jelena S  ;
Conference Paper
Mp. category will be shown later
2013Stem cell-based (auto)grafting: from innovative research toward clinical use in regenerative medicineMihaljević, Biljana ; Todorović, Milena  ; Balint, Bela  ; Obradović, Slobodan  ; Pavlovic MBook parts
Mp. category will be shown later
2013CD5-positive versus CD5-negative diffuse large B-cell lymphoma treated with immunochemotherapy: Is there a difference? (Meeting Abstract)Popovic Ljubomir; Marković, Olivera  ; JOVANOVIĆ, DARJANA; Marisavljević, Dragomir  ; Petrovic Dragana; Mihaljević, Biljana ; Popovic Marina; Matkovic Tatjana; Matovina-Brko Gorana; Zivkovic Radmila RConference Paper
Mp. category will be shown later
2013c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphomaMarković, Olivera  ; Marisavljević, Dragomir  ; Cemerikic-Martinovic, Vesna; Filipović, Branka  ; Radovanović, Slavica; Zdravković, Marija  ; Stanisavljević, Dejana  ; Mihaljević, Biljana Article
22M22
2013Differences in baseline characteristics and survival rates between GCB and non-GCB diffuse large B-cell lymphoma treated with rituximab based immunochemotherapy (Meeting Abstract)Popovic Ljubomir; Marković, Olivera  ; JOVANOVIĆ, DARJANA; Marisavljević, Dragomir  ; Petrovic Dragana; Mihaljević, Biljana ; NIKIN, ZORAN; Matkovic Tatjana; Matovina-Brko Gorana; Zivkovic RadmilaConference Paper
Mp. category will be shown later
2013Pharmacokinetics (PK), safety and overall response rate (ORR) achieved with subcutaneous (SC) administration of rituximab in combination with chemotherapy were comparable to those achieved with intravenous (IV) administration in patients (pts) with follicDavies, AJ; Merli, Francesco; Mihaljevic, Biljana S ; Siritanaratkul, Noppadol; Solal-Celigny, Philippe; Boehnke, Axel; Berge, Claude; McIntyre, Christine; Barrett, M; MacDonald, DConference Paper
Mp. category will be shown later
2013Blast crisis of chronic myeloid leukemia: laboratory, immunophenotypc, and cytogenetic hallmarks and response to therapyVidović, A.  ; Janković, G.; Tomin, D.; Suvajdžić, Nada  ; Djunić, I.; Čolović, Nataša; Virijević, M.  ; Mitrović, M.; Bogdanović, A.  ; Kurtović, N.;
Đorđević, V.; Fekete, M.; Pavlović, Sonja  ; Perunicić, M.; Mihaljević, B. ;
Conference Paper
Mp. category will be shown later